Manufactures wearable devices that deliver transcranial electromagnetic and radiofrequency treatments designed to improve brain health.
NeuroEM has raised $1.3M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
NeuroEM's investors include New York Angels, Bluelake.
NeuroEM is headquartered in Tampa, United States.
Manufactures wearable devices that deliver transcranial electromagnetic and radiofrequency treatments designed to improve brain health.
NeuroEM is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroEM — Funding & Investors." VCBacked, June 13, 2025, https://www.vcbacked.co/company/neuroem. Accessed August 5, 2026.
VCBacked. (2025). NeuroEM — Funding & Investors. Retrieved August 5, 2026, from https://www.vcbacked.co/company/neuroem
{{cite web |title=NeuroEM — Funding & Investors |url=https://www.vcbacked.co/company/neuroem |website=VCBacked |access-date=August 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated